Patients with a rheumatological diagnosis in a psychiatrist's office -neuropsychiatric lupus
DOI:
https://doi.org/10.12923/2353-8627/2024-0007Keywords:
systemic lupus erythematosus, sleep disorders, mood disorders, neuropsychiatric systemic lupus erythematosus, mental disordersAbstract
Introduction: Systemic lupus erythematosus is an autoimmune disease affecting up to 210 per 100,000 people in Europe, more often among women. The inflammatory process in lupus causes changes in various organs. However, somatic changes are not the only effects of lupus. The neuropsychiatric manifestations of this disease have been given a separate name – neuropsychiatric lupus.
Material and methods: A review of the literature available on the PubMed platform in the period of 1987-2023 was performed using the key words: neuropsychiatric systemic lupus erythematosus, mental disorders, mood disorders, sleep disorders, systemic lupus erythematosus. Original studies, review works, meta-analyses and Internet sources were analyzed.
Results: Psychotic disorders in lupus occur with a frequency of up to 3%. Risk factors include young age, male gender and glucocorticoids treatment. Mood disorders occur in several to several dozen percent of lupus patients, including depression affecting up to ⅓ of patients. Belimumab, psychotherapy and improving the quality of sleep, the disturbance of which is observed in most patients with lupus, have potential in treatment. Anxiety disorders are seen primarily in the teenage age group, where social phobia predominates – the fear of rejection due to the disease – and they worsen and are exacerbated by rheumatic disease. Cognitive dysfunctions occur in up to 80% of lupus patients. They are probably related to enzymes of metabolic pathways, dyslipidemia and thyroid dysfunction.
Conclusions: Mental disorders develop more often in patients with lupus than in the general population and they predispose to autoimmune diseases. Comprehensive diagnosis and psychiatric care of patients with lupus are necessary.
References
1. Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al. 2019 EULAR/ACR Classification Criteria for Systemic Lupus Erythematosus. Arthritis Rheumatol. 2019;71(9):1400.
2. Barber MRW, Drenkard C, Falasinnu T, Hoi A, Mak A, Kow NY, et al. Global epidemiology of systemic lupus erythematosus. Nature Reviews Rheumatology 2021 17:9. 2021;17(9):515-32. Review match
3. Hermansen MLF, Lindhardsen J, Torp-Pedersen C, Faurschou M, Jacobsen S. Incidence of Systemic Lupus Erythematosus and Lupus Nephritis in Denmark: A Nationwide Cohort Study. J Rheumatol. 2016;43(7):1335-9. Review match
4. Rees F, Doherty M, Grainge M, Davenport G, Lanyon P, Zhang W. The incidence and prevalence of systemic lupus erythematosus in the UK, 1999-2012. Ann Rheum Dis. 2016;75(1):136-41. Review match
5. Simard JF, Sjöwall C, Rönnblom L, Jönsen A, Svenungsson E. Systemic lupus erythematosus prevalence in Sweden in 2010: what do national registers say? Arthritis Care Res (Hoboken). 2014;66(11):1710-7. Review match
6. Arnaud L, Fagot JP, Mathian A, Paita M, Fagot-Campagna A, Amoura Z. Prevalence and incidence of systemic lupus erythematosus in France: a 2010 nation-wide population-based study. Autoimmun Rev. 2014;13(11):1082-9. Review match
7. Lee YH, Choi SJ, Ji JD, Song GG. Overall and cause-specific mortality in systemic lupus erythematosus: an updated metaanalysis. Lupus. 2016;25(7):727-34. Review match
8. Zardi EM, Giorgi C, Zardi DM. Diagnostic approach to neuropsychiatric lupus erythematosus: what should we do? Postgrad Med. 2018;130(6):536-47. Review match
9. Meszaros ZS, Perl A, Faraone S V. Psychiatric Symptoms in Systemic Lupus Erythematosus: A Systematic Review. J Clin Psychiatry. 2012;73(7):993. Review match
10. Gordon C, Alarcón GS, Straaton K V, Esdaile JM, Pack Arthritis Center M, Columbia B, et al. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum. 1999;42(4):599-608.
11. Sarwar S, Mohamed AS, Rogers S, Sarmast ST, Kataria S, Mohamed KH, et al. Neuropsychiatric Systemic Lupus Erythematosus: A 2021 Update on Diagnosis, Management, and Current Challenges. Cureus. 2021;13(9). Review match
12. Fernandez H, Cevallos A, Jimbo Sotomayor R, Naranjo-Saltos F, Mera Orces D, Basantes E. Mental disorders in systemic lupus erythematosus: a cohort study. Rheumatol Int. 2019;39(10):1689-95. Review match
13. Abrol E, Coutinho E, Chou M, Hart M, Vincent A, Howard R, et al. Psychosis in systemic lupus erythematosus (SLE): 40-year experience of a specialist centre. Rheumatology (Oxford). 2021;60(12):5620-9. Review match
14. Elefante E, Tani C, Stagnaro C, Signorini V, Lenzi B, Zucchi D, et al. Self-Reported Anxiety and Depression in a Monocentric Cohort of Patients With Systemic Lupus Erythematosus: Analysis of Prevalence, Main Determinants, and Impact on Quality of Life. Front Med (Lausanne). 2022;9. Review match
15. Moustafa AT, Moazzami M, Engel L, Bangert E, Hassanein M, Marzouk S, et al. Prevalence and metric of depression and anxiety in systemic lupus erythematosus: A systematic review and meta-analysis. Semin Arthritis Rheum. 2020;50(1):84-94. Review match
16. Perera S, Cook R, Lee KA, Katz P, Touma Z. Intraindividual Change in Cognitive Function Among Adults With Systemic Lupus Erythematosus: A Markov Analysis Over 7 Years. ACR Open Rheumatol. 2023;5(3):124. Review match
17. Rayes H Al, Tani C, Kwan A, Marzouk S, Colosimo K, Medina-Rosas J, et al. What is the prevalence of cognitive impairment in lupus and which instruments are used to measure it? A systematic review and meta-analysis. Semin Arthritis Rheum. 2018;48(2):240-55. Review match
18. Govoni M, Hanly JG. The management of neuropsychiatric lupus in the 21st century: still so many unmet needs? Rheumatology (Oxford). 2020;59(Suppl 5):v52. 19. Review match
19. Palagini L, Tani C, Mauri M, Carli L, Vagnani S, Bombardieri S, et al. Sleep disorders and systemic lupus erythematosus. Lupus. 2014;23(2):115-23. Review match
20. Hanly JG, Li Q, Su L, Urowitz MB, Gordon C, Bae SC, et al. Psychosis in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study. Arthritis Rheumatol. 2019;71(2):281-9. Review match
21. Pego-reigosa JM, Isenberg DA. Psychosis due to systemic lupus erythematosus: characteristics and long-term outcome of this rare manifestation of the disease. Rheumatology. 2008;47(10):1498-502. Review match
22. Kumar P, Kumar A, Thakur V, Sharma CB, Thomas A, Chatterjee S. Acute psychosis as the presenting manifestation of lupus. J Family Med Prim Care. 2021;10(2):1050. Review match
23. Lieberman JA, First MB. Psychotic Disorders. Ropper AH, editor. N Engl J Med. 2018;379(3):270-80.
24. Bogaczewicz A, Sobów T, Bogaczewicz J, Ząbek J, Bieńkowski P, Kowalski J, et al. Zaburzenia psychiczne w toczniu rumieniowatym układowym. Aktualności Neurologiczne - Current Neurology. 2013;13(3):168-78.
25. Stelmach E, Masiak J. Case Report: Psychopathological Syndromes in the Course of Lupus Erythematosus and the Cooccurrence of Lupus Erythematous With Mental Disorders. Front Psychiatry. 2021;12. Review match
26. Bonfa E, Golombek SJ, Kaufman LD, Skelly S, Weissbach H, Brot N, et al. Association between lupus psychosis and anti-ribosomal P protein antibodies. N Engl J Med. 1987;317(5):265-71. Review match
27. Karassa FB, Afeltra A, Ambrozic A, Chang DM, De Keyser F, Doria A, et al. Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis. Arthritis Rheum. 2006;54(1):312-24. Review match
28. Viana VT, Durcan L, Bonfa E, Elkon KB. Ribosomal P antibody: 30 years on the road. Lupus. 2017;26(5):453-62. Review match
29. Tokunaga M, Saito K, Kawabata D, Imura Y, Fujii T, Nakayamada S, et al. Efficacy of rituximab (anti‐CD20) for refractory systemic lupus erythematosus involving the central nervous system. Ann Rheum Dis. 2007;66(4):470. Review match
30. Fernandes Moça Trevisani V, Castro AA, Ferreira Neves Neto J, Atallah ÁN. Cyclophosphamide versus methylprednisolone for treating neuropsychiatric involvement in systemic lupus erythematosus. Cochrane Database of Systematic Reviews. 2013;2013(2). Review match
31. Chand SP, Arif H. Depression. StatPearls. 2022;
32. N S. Depression and diabetes. Dialogues Clin Neurosci. 2018;20(1).
33. Zis P, Daskalaki A, Bountouni I, Sykioti P, Varrassi G, Paladini A. Depression and chronic pain in the elderly: links and management challenges. Clin Interv Aging. 2017;12:709-20. Review match
34. Hare DL, Toukhsati SR, Johansson P, Jaarsma T. Depression and cardiovascular disease: a clinical review. Eur Heart J. 2014;35(21):1365-72. Review match
35. Zhang L, Fu T, Yin R, Zhang Q, Shen B. Prevalence of depression and anxiety in systemic lupus erythematosus: A systematic review and meta-analysis. BMC Psychiatry. 2017;17(1):1-14.
36. Abd-Alrasool ZA, Gorial FI, Hashim MT. Prevalence and severity of depression among Iraqi patients with systemic lupus erythematosus: A descriptive study. Mediterr J Rheumatol. 2017;28(3):142-6. Review match
37. Patterson SL, Trupin L, Yazdany J, Dall’Era M, Lanata C, Dequattro K, et al. Physical Inactivity and Incident Depression in a Multiracial, Multiethnic Systemic Lupus Erythematosus Cohort. Arthritis Care Res (Hoboken). 2022;74(7):1098-104. Review match
38. Mccormick N, Trupin L, Yelin EH, Katz PP. Socioeconomic Predictors of Incident Depression in Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2018;70(1):104-13. Review match
39. Eldeiry D, Zandy M, Tayer-Shifman OE, Kwan A, Marzouk S, Su J, et al. Association between depression and anxiety with skin and musculoskeletal clinical phenotypes in systemic lupus erythematosus. Rheumatology (Oxford). 2020;59(11):3211-20. Review match
40. Hong J, Aspey L, Bao G, Haynes T, Lim SS, Drenkard C. Chronic Cutaneous Lupus Erythematosus: Depression Burden and Associated Factors. Am J Clin Dermatol. 2019;20(3):465-75. Review match
41. Jorge A, Lertratanakul A, Lee J, Pearce W, McPherson D, Thompson T, et al. Depression and Progression of Subclinical Cardiovascular Disease in Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2017;69(1):5. Review match
42. Lillis TA, Tirone V, Gandhi N, Weinberg S, Nika A, Sequeira W, et al. Sleep Disturbance and Depression Symptoms Mediate Relationship Between Pain and Cognitive Dysfunction in Lupus. Arthritis Care Res (Hoboken). 2019;71(3):406-12. Review match
43. Monahan RC, Beaart-van de Voorde LJJ, Eikenboom J, Fronczek R, Kloppenburg M, Middelkoop HAM, et al. Fatigue in patients with systemic lupus erythematosus and neuropsychiatric symptoms is associated with anxiety and depression rather than inflammatory disease activity. Lupus. 2021;30(7):1124-32. Review match
44. Khan WA, Zaman GS, Alouffi S, Khan MWA. Depression and its related parameters increased the production of autoantibodies 6α-hydroxyestrone-albumin complex in systemic lupus erythematosus. Int Immunopharmacol. 2019;71:215-23. Review match
45. Zhang F, Zheng J, Li Y, Wang G, Wang M, Su Y, et al. Phase 3, long-term, open-label extension period of safety and efficacy of belimumab in patients with systemic lupus erythematosus in China, for up to 6 years. RMD Open. 2022;8(1). Review match
46. Xie W, Huang H, Zhan S, Zhang Z. Risk of psychiatric disorders and all-cause mortality with belimumab therapy in patients with systemic lupus erythematosus: a meta-analysis of randomised controlled trials. Lupus Sci Med. 2021;8(1). Review match
47. Conceição CTM, Meinão IM, Bombana JA, Sato EI. Psychoanalytic psychotherapy improves quality of life, depression, anxiety and coping in patients with systemic lupus erythematosus: a controlled randomized clinical trial. Adv Rheumatol. 2019;59(1):4. Review match
48. Gavilán-Carrera B, Vargas-Hitos JA, Morillas-de-Laguno P, Rosales-Castillo A, Sola-Rodríguez S, Callejas-Rubio JL, et al. Effects of 12-week aerobic exercise on patient-reported outcomes in women with systemic lupus erythematosus. Disabil Rehabil. 2022;44(10):1863-71. Review match
49. Bogdanovic G, Stojanovich L, Djokovic A, Stanisavljevic N. Physical Activity Program Is Helpful for Improving Quality of Life in Patients with Systemic Lupus Erythematosus. Tohoku J Exp Med. 2015;237(3):193-9. Review match
50. Tench C, Bentley D, Vleck V, McCurdie I, White P, D’Cruz D. Aerobic fitness, fatigue, and physical disability in systemic lupus erythematosus. J Rheumatol. 2002;29(3).
51. Belmaker RH. Bipolar disorder. N Engl J Med. 2004;351(5):476-86.
52. Tiosano S, Nir Z, Gendelman O, Comaneshter D, Amital H, Cohen AD, et al. The association between systemic lupus erythematosus and bipolar disorder – a big data analysis. European Psychiatry. 2017;43:116-9. Review match
53. Manorenj S, Shaik R. Chronic psychiatric illness masquerading as bipolar disorder in a family secondary to familial systemic lupus erythematosus with limbic encephalitis. Indian J Psychiatry. 2021;63(5):517-9. Review match
54. Alao AO, Chlebowski S, Chung C. Neuropsychiatric systemic lupus erythematosus presenting as bipolar I disorder with catatonic features. Psychosomatics. 2009;50(5):543-7. Review match
55. Carta M, Hardoy M, Ducci F, Catena M, Dell’Osso L, Carpinello B. Gabapentin in the treatment of bipolar depression in patients with systemic lupus erythematosus. Clin Exp Rheumatol. 2004;22(3):266.
56. Brey RL, Holliday SL, Saklad AR, Navarrete MG, Hermosillo-Romo D, Stallworth CL, et al. Neuropsychiatric syndromes in lupus: prevalence using standardized definitions. Neurology. 2002;58(8):1214-20. Review match
57. Nayak RB, Bhogale GS, Patil NM, Chate SS. Psychosis in Patients with Systemic Lupus Erythematosus. Indian J Psychol Med. 2012;34(1):90. Review match
58. Khan S, Haddad P, Montague L, Summerton C. Systemic lupus erythematosus presenting as mania. Acta Psychiatr Scand. 2000;101(5):406-8. Review match
59. Vaseel M, Uvais NA, Moideen S, Sukesh E. Systemic Lupus Erythematosus Presenting as Mania. Prim Care Companion CNS Disord. 2023;25(3). Review match
60. Tisseverasinghe A, Peschken C, Hitchon C. Anxiety and Mood Disorders in Systemic Lupus Erythematosus: Current Insights and Future Directions. Curr Rheumatol Rep. 2018;20(12):1-11. Review match
61. Kivity S, Agmon-Levin N, Zandman-Goddard G, Chapman J, Shoenfeld Y. Neuropsychiatric lupus: A mosaic of clinical presentations. BMC Med. 2015;13(1):1-11. Review match
62. Govoni M, Bortoluzzi A, Padovan M, Silvagni E, Borrelli M, Donelli F, et al. The diagnosis and clinical management of the neuropsychiatric manifestations of lupus. J Autoimmun. 2016;74:41-72. Review match
63. Shortall E, Isenberg D, Newman SP. Factors associated with mood and mood disorders in SLE. Lupus. 1995;4(4):272-9. Review match
64. Nowicka-Sauer K, Hajduk A, Kujawska-Danecka H, Banaszkiewicz D, Smoleńska, Czuszyńska Z, et al. Illness perception is significantly determined by depression and anxiety in systemic lupus erythematosus. Lupus. 2018;27(3):454-60. Review match
65. Peralta-Ramírez MI, Pérez-Mármol JM, Castañeda-Cabestany M, Santos-Ruiz AM, Montero-López E, Callejas-Rubio JL, et al. Association between perceived level of stress, clinical characteristics and psychopathological symptoms in women with systemic lupus erythematosus. Clin Exp Rheumatol. 2018;36(3):0434-41.
66. Kozora E, Ellison MC, Waxmonsky JA, Wamboldt FS, Patterson TL. Major life stress, coping styles, and social support in relation to psychological distress in patients with systemic lupus erythematosus. http://dx.doi. org/101191/0961203305lu2094oa. 2005;14(5):363-72. Review match
67. Lew D, Huang X, Kellahan SR, Xian H, Eisen S, Kim AHJ. Anxiety Symptoms Among Patients With Systemic Lupus Erythematosus Persist Over Time and Are Independent of SLE Disease Activity. ACR Open Rheumatol. 2022;4(5):432. Review match
68. Watson P, Storbeck J, Mattis P, Mackay M. Cognitive and emotional abnormalities in systemic lupus erythematosus: evidence for amygdala dysfunction. Neuropsychol Rev. 2012;22(3):252-70. Review match
69. Bundhun PK, Kumari A, Huang F. Differences in clinical features observed between childhood-onset versus adult-onset systemic lupus erythematosus: A systematic review and meta-analysis. Medicine. 2017;96(37). Review match
70. Quilter M, Hiraki L, Knight AM, Couture J, Levy D, Silverman ED, et al. Evaluation of self-report screening measures in the detection of depressive and anxiety disorders among children and adolescents with systemic lupus erythematosus. Lupus. 2021;30(8):1327-37. Review match
71. Davis AM, Graham TB, Zhu Y, McPheeters ML. Depression and medication nonadherence in childhood-onset systemic lupus erythematosus. Lupus. 2018;27(9):1532-41. Review match
72. Knight A, Weiss P, Morales K, Gerdes M, Gutstein A, Vickery M, et al. Depression and anxiety and their association with healthcare utilization in pediatric lupus and mixed connective tissue disease patients: a cross-sectional study. Pediatr Rheumatol Online J. 2014;12(1). Review match
73. Bhangle SD, Kramer N, Rosenstein ED. Corticosteroid-induced neuropsychiatric disorders: review and contrast with neuropsychiatric lupus. Rheumatol Int. 2013;33(8):1923-32. Review match
74. Jones JT, Cunningham N, Kashikar-Zuck S, Brunner HI. Pain, Fatigue, and Psychological Impact on Health-Related Quality of Life in Childhood-Onset Lupus. Arthritis Care Res (Hoboken). 2016;68(1):73-80. Review match
75. Livingston B, Bonner A, Pope J. Differences in clinical manifestations between childhood-onset lupus and adult-onset lupus: a meta-analysis. Lupus. 2011;20(13):1345-55. Review match
76. Roseman M, Kloda LA, Saadat N, Riehm KE, Ickowicz A, Baltzer F, et al. Accuracy of Depression Screening Tools to Detect Major Depression in Children and Adolescents: A Systematic Review. Can J Psychiatry. 2016;61(12):746-57. Review match
77. Simmons M, Wilkinson P, Dubicka B. Measurement Issues: Depression measures in children and adolescents. Child Adolesc Ment Health. 2015;20(4):230-41. Review match
78. Quilter MC, Hiraki LT, Korczak DJ. Depressive and anxiety symptom prevalence in childhood-onset systemic lupus erythematosus: A systematic review. Lupus. 2019;28(7):878-87. Review match
79. Langensee L, Mårtensson J, Jönsen A, Zervides K, Bengtsson A, Nystedt J, et al. Cognitive performance in systemic lupus erythematosus patients: a cross-sectional and longitudinal study. BMC Rheumatol. 2022;6(1):1-11. Review match
80. Barraclough M, McKie S, Parker B, Elliott R, Bruce IN. The effects of disease activity, inflammation, depression and cognitive fatigue on resting state fMRI in systemic lupus erythematosus. Rheumatology. 2022;61(SI):SI39-47. Review match
81. Brey RL. Neuropsychiatric lupus: clinical and imaging aspects. Bull NYU Hosp Jt Dis. 2007;65(3):194-194.
82. Hanly G J, McCyrdy G, Fougere L, Douglas JA, Thompson K. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance. | The Journal of Rheumatology. J Rheumatol. 2004;31(11):2156-62. Review match
83. Mackay M. Lupus brain fog: a biologic perspective on cognitive impairment, depression, and fatigue in systemic lupus erythematosus. Immunol Res. 2015;63(1-3):26-37. Review match
84. Hanly JG, Kozora E, Beyea SD, Birnbaum J. Review: Nervous System Disease in Systemic Lupus Erythematosus: Current Status and Future Directions. Arthritis Rheumatol. 2019;71(1):33-42. Review match
85. Sweet JJ, Doninger NA, Zee PC, Wagner LI. Factors influencing cognitive function, sleep, and quality of life in individuals with systemic lupus erythematosus: a review of the literature. Clin Neuropsychol. 2004;18(1):132-47. Review match
86. Lynall M. Neuropsychiatric symptoms in lupus. Lupus. 2018;27(1_suppl):18-20. Review match
87. Seet D, Allameen NA, Tay SH, Cho J, Mak A. Cognitive Dysfunction in Systemic Lupus Erythematosus: Immunopathology, Clinical Manifestations, Neuroimaging and Management. Rheumatol Ther. 2021;8(2):651. Review match
88. Khan MI, Qureshi H, Akhtar S, Bae SJ, Hassan F. Prevalence of neuropsychiatric disorders in patients with systemic lupus erythematosus in Pakistan: A systematic review and metaanalysis. Front Psychiatry. 2023;14:1098734. Review match
89. Zhang Y, Han H, Chu L. Neuropsychiatric Lupus Erythematosus: Future Directions and Challenges; a Systematic Review and Survey. Clinics (Sao Paulo). 2020;75. Review match
90. Anderson EW, Fishbein J, Hong J, Roeser J, Furie RA, Aranow C, et al. Original research: Quinolinic acid, a kynurenine/tryptophan pathway metabolite, associates with impaired cognitive test performance in systemic lupus erythematosus. Lupus Sci Med. 2021;8(1):559. Review match
91. Lu L, Kong W, Zhou K, Chen J, Hou Y, Dou H, et al. Association of lipoproteins and thyroid hormones with cognitive dysfunction in patients with systemic lupus erythematosus. BMC Rheumatol. 2021;5(1). Review match
92. Raghunath S, Guymer EK, Glikmann-Johnston Y, Golder V, Kandane Rathnayake R, Morand EF, et al. Fibromyalgia, mood disorders, cognitive test results, cognitive symptoms and quality of life in systemic lupus erythematosus. Rheumatology. 2022;62(1):190-9. Review match
93. Panopalis P, Julian L, Yazdany J, Gillis JZ, Trupin L, Hersh A, et al. Impact of memory impairment on employment status in persons with systemic lupus erythematosus. Arthritis Rheum. 2007;57(8):1453-60. Review match
94. Appenzeller S, Cendes F, Costallat LTL. Cognitive impairment and employment status in systemic lupus erythematosus: a prospective longitudinal study. Arthritis Rheum. 2009;61(5):680-7. Review match
95. Arntsen KA, Raymond SC, Farber KM. Lupus: Patient Voices Report on Externally-led Patient-Focused Drug Development Meeting A Message of Gratitude.
96. Ho RC, Husain SF, Ho CS. Cognitive dysfunction in patients with systemic lupus erythematosus: The challenge in diagnosis and management. https://doi.org/101177/2059902118792434. 2018;3:205990211879243. Review match
97. Raghunath S, Glikmann-Johnston Y, Hanly JG, Morand EF, Stout JC, Hoi A. Cognitive dysfunction in systemic lupus erythematosus: how do we advance our understanding? Lancet Rheumatol. 2022;4(4):e293-302. Review match
98. Magro-Checa C, Zirkzee EJ, Huizinga TW, Steup-Beekman GM. Management of Neuropsychiatric Systemic Lupus Erythematosus: Current Approaches and Future Perspectives. Drugs. 2016;76(4):459. Review match
99. Carrión-Barberà I, Salman-Monte TC, Vílchez-Oya F, Monfort J. Neuropsychiatric involvement in systemic lupus erythematosus: A review. Autoimmun Rev. 2021;20(4):102780. Review match
100. Natoli V, Charras A, Hahn G, Hedrich CM. Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus (jSLE). Mol Cell Pediatr. 2023;10(1). Review match
101. Magro-Checa C, Steup-Beekman GM, Huizinga TW, van Buchem MA, Ronen I. Laboratory and Neuroimaging Biomarkers in Neuropsychiatric Systemic Lupus Erythematosus: Where Do We Stand, Where To Go? Front Med (Lausanne). 2018;5:340. Review match
102. Kiriakidou M, Ching CL. Systemic Lupus Erythematosus. Ann Intern Med. 2020;172(11):ITC82-96.
103. Trysberg E, Carlsten H, Tarkowski A. Intrathecal cytokines in systemic lupus erythematosus with central nervous system involvement. Lupus. 2000;9(7):498-503. Review match
104. Asano T, Ito H, Kariya Y, Hoshi K, Yoshihara A, Ugawa Y, et al. Evaluation of blood-brain barrier function by quotient alpha2 macroglobulin and its relationship with interleukin-6 and complement component 3 levels in neuropsychiatric systemic lupus erythematosus. PLoS One. 2017;12(10). Review match
105. Hirohata S, Kikuchi H. Role of Serum IL-6 in Neuropsychiatric Systemic lupus Erythematosus. ACR Open Rheumatol. 2021;3(1):42-9. Review match
106. Moore E, Huang MW, Putterman C. Advances in the diagnosis, pathogenesis and treatment of neuropsychiatric systemic lupus erythematosus. Curr Opin Rheumatol. 2020;32(2):152. Review match
107. Narváez J, Ríos-Rodriguez V, de la Fuente D, Estrada P, López-Vives L, Gómez-Vaquero C, et al. Rituximab therapy in refractory neuropsychiatric lupus: current clinical evidence. Semin Arthritis Rheum. 2011;41(3):364-72. Review match
108. Chokroverty S. Overview of sleep & sleep disorders. Indian Journal of Medical Research. 2010;131(2):126-40.
109. Louter M, Aarden WCCA, Lion J, Bloem BR, Overeem S. Recognition and diagnosis of sleep disorders in Parkinson’s disease. J Neurol. 2012;259(10):2031-40. Review match
110. Kuang H, Zhu YG, Zhou ZF, Yang MW, Hong FF, Yang SL. Sleep disorders in Alzheimer’s disease: the predictive roles and potential mechanisms. Neural Regen Res. 2021;16(10):1965-72. Review match
111. Kaskie RE, Graziano B, Ferrarelli F. Schizophrenia and sleep disorders: links, risks, and management challenges. Nat Sci Sleep. 2017;9:227-39. Review match
112. Nutt DJ, Wilson S, Paterson L. Sleep disorders as core symptoms of depression. Dialogues Clin Neurosci. 2008;10(3):329-36. Review match
113. Green ME, Bernet V, Cheung J. Thyroid Dysfunction and Sleep Disorders. Front Endocrinol (Lausanne). 2021;12.
114. Wu L, Shi PL, Tao SS, Tao JH, Wu GC. Decreased sleep quality in patients with systemic lupus erythematosus: a meta-analysis. Clin Rheumatol. 2021;40(3):913-22. Review match
115. Sahebari M, Ravanshad S, Ravanshad Y, Rezaeitalab F, Bayegi HRP, Asadpour H, et al. A Survey on Sleep Disorders and Related Hormones in Patients with Newly Diagnosed Systemic Lupus Erythematosus. Mediterr J Rheumatol. 2021;32(2):148-57. Review match
116. Cervilla O, Miró E, Martínez MP, Sánchez AI, Sabio JM, Prados G. Sleep quality and clinical and psychological manifestations in women with mild systemic lupus erythematosus activity compared to women with fibromyalgia: A preliminary study. Mod Rheumatol. 2020;30(6):1016-24. Review match
117. Özer S, Kankaya H, Gün R, Yeler N, Marangoz Ö, Bozça H. Factors affecting sleep quality in patients with systemic lupus erythematosus. Lupus. 2022;31(1):39-44. Review match
118. Young KA, Munroe ME, Harley JB, Guthridge JM, Kamen DL, Gilkensen GS, et al. Less than 7 hours of sleep per night is associated with transitioning to systemic lupus erythematosus. Lupus. 2018;27(9):1524-31. Review match
119. Wu ML, Tsai JC, Yu KH, Chen JJ. Effects of physical activity counselling in women with systemic lupus erythematosus: A randomized controlled trial. Int J Nurs Pract. 2019;25(5). Review match
120. Davies RJ, Lomer M, Yeo SI, Avloniti K, Sangle SR, D’Cruz DP. Weight loss and improvements in fatigue in systemic lupus erythematosus: a controlled trial of a low glycaemic index diet versus a calorie restricted diet in patients treated with corticosteroids. Lupus. 2012;21(6):649-55. Review match
121. Castrejón I, Yazici Y, Samuels J, Luta G, Pincus T. Discordance of global estimates by patients and their physicians in usual care of many rheumatic diseases: association with 5 scores on a Multidimensional Health Assessment Questionnaire (MDHAQ) that are not found on the Health Assessment Questionnaire (HAQ). Arthritis Care Res (Hoboken). 2014;66(6):934-42. Review match
122. Malec-Litwinowicz MH, Rudzińska M, Dudek D, Siwek M, Wnuk M, Szczudlik A. Psychotic disorder in the course of Systemic Lupus Erythematosus with subcortical calcifications- case report. Psychiatr Pol. 2014;48(2):299-306.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Authors
This work is licensed under a Creative Commons Attribution 4.0 International License.
